Related Experiment Video
Updated: Jun 21, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity
Emilie Duval1, Céline Zatylny, Mathieu Laurencin
1UMR 100 IFREMER Physiologie et Ecophysiologie des Mollusques Marins, Université de Caen, Caen cedex, France.
A novel de novo peptide, K4, demonstrates potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including human pathogens. Importantly, K4 exhibits no toxicity to mammalian cells at effective concentrations, suggesting therapeutic potential.
Area of Science:
- Biochemistry
- Microbiology
- Drug Discovery
Background:
- The rise of antibiotic resistance necessitates the development of novel antimicrobial agents.
- De novo peptide design offers a promising avenue for creating new therapeutics with unique mechanisms of action.
Purpose of the Study:
- To design and characterize a novel de novo peptide, K4, with potent antibacterial properties.
- To evaluate the efficacy and safety profile of K4 against a range of bacterial pathogens and mammalian cells.
Main Methods:
- Peptide design utilizing the Antimicrobial Peptide Database.
- Chemical synthesis, purification, and structural verification of the K4 peptide.
- Antibacterial assays against Gram-positive and Gram-negative bacteria, including pathogenic strains.
- Scanning electron microscopy to visualize bacterial cell lysis.
- Cytotoxicity assays using rabbit erythrocytes and Chinese Hamster Ovary (CHO-K1) cells.
Main Results:
- The de novo peptide K4, featuring two domains and 14 residues, was successfully synthesized and characterized.
- K4 exhibited significant antibacterial activity against Gram-positive (e.g., Staphylococcus aureus) and Gram-negative bacteria (e.g., Vibrio species, Escherichia coli).
- Scanning electron microscopy confirmed K4-induced lysis of Escherichia coli cells.
- K4 demonstrated a favorable safety profile, showing no toxicity to mammalian cells at bacteriolytic concentrations.
Conclusions:
- The designed peptide K4 possesses broad-spectrum antibacterial activity.
- K4 effectively lyses bacterial cells without harming mammalian cells.
- K4 represents a promising candidate for the development of new antimicrobial therapeutics.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing

